Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1990;81:1784-1791

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Aoyama, T.
Right arrow Articles by Kawai, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Aoyama, T.
Right arrow Articles by Kawai, C.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Medline Plus Health Information
*Angina
*Heart Attack

Circulation, Vol 81, 1784-1791, Copyright © 1990 by American Heart Association


ARTICLES

Prostaglandin I2 half-life regulated by high density lipoprotein is decreased in acute myocardial infarction and unstable angina pectoris

T Aoyama, Y Yui, H Morishita and C Kawai
Department of Internal Medicine, Faculty of Medicine, Kyoto University, Japan.

To investigate the prostaglandin I2 (PGI2) half-life regulated by high density lipoprotein (HDL) in patients with coronary artery disease (CAD), we determined the stability of PGI2 and serum apolipoprotein A-I (Apo A-I) and apolipoprotein A-II (Apo A-II) levels in four age-matched groups of patients: controls (n = 17), angina pectoris (n = 18), unstable angina pectoris (n = 17), myocardial infarction (n = 19) (acute phase, 3.6 +/- 1.7 hours from onset; subacute phase, 75 +/- 15 hours from onset in the same patients). Serum PGI2 half-life and total serum Apo A-I levels were lower in the CAD group than in the control group. PGI2 was least stable in patients with unstable angina and the acute phase of myocardial infarction. In these patients, the molar ratio of Apo A-I to Apo A-II and HDL-associated Apo A-I levels were decreased, and free Apo A-I levels were increased. After in vitro incubation of HDL with increasing amounts of Apo A-II, Apo A-I in HDL was displaced by Apo A-II, with the parallel decrease in stability of PGI2. Free Apo A-I cannot stabilize PGI2. HDL-associated Apo A-I, whose amount is affected by Apo A-II, stabilized PGI2 and correlated well with stability of PGI2 in patients with CAD and control patients. Decreased PGI2 half-life may play an important role in the pathogenesis of atherosclerosis and thrombus formation in the coronary arteries, especially thrombus formation during an acute coronary event.


This article has been cited by other articles:


Home page
Circ. Res.Home page
L. Calabresi, G. Rossoni, M. Gomaraschi, F. Sisto, F. Berti, and G. Franceschini
High-Density Lipoproteins Protect Isolated Rat Hearts From Ischemia-Reperfusion Injury by Reducing Cardiac Tumor Necrosis Factor-{alpha} Content and Enhancing Prostaglandin Release
Circ. Res., February 21, 2003; 92(3): 330 - 337.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
K. Miwa, N. Yoshida, K. Nakagawa, and H. Inoue
High-density lipoprotein particles are large in patients with variant angina
Cardiovasc Res, March 1, 1998; 37(3): 729 - 737.
[Abstract] [Full Text] [PDF]


Home page
Arch Intern MedHome page
R. S. Rosenson
Beyond Low-Density Lipoprotein Cholesterol: A Perspective on Low High-Density Lipoprotein Disorders and Lp(a) Lipoprotein Excess
Arch Intern Med, June 24, 1996; 156(12): 1278 - 1284.
[Abstract] [PDF]


Home page
Circ. Res.Home page
M. R. Soma, E. Donetti, C. Parolini, C. R. Sirtori, R. Fumagalli, and G. Franceschini
Recombinant Apolipoprotein A-IMilano Dimer Inhibits Carotid Intimal Thickening Induced by Perivascular Manipulation in Rabbits
Circ. Res., March 1, 1995; 76(3): 405 - 411.
[Abstract] [Full Text]


Home page
Arch Intern MedHome page
R. S. Rosenson
Low Levels of High-Density Lipoprotein Cholesterol (Hypoalphalipoproteinemia) An Approach to Management
Arch Intern Med, July 12, 1993; 153(13): 1528 - 1538.
[Abstract] [PDF]